xanomeline has been researched along with quinuclidines in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barg, Y; Brandeis, R; Fisher, A; Ginzburg, I; Gurwitz, D; Haring, R; Heldman, E; Karton, Y; Klimowsky, S; Korczyn, AD; Marciano, D; Meshulam, H; Pinkas-Kramarski, R; Pittel, Z; Sadot, E; Treves, TA; Verchovsky, R; Vogel, Z | 1 |
| Bymaster, FP; Calligaro, DO; Carter, PA; DeLapp, N; Fink-Jensen, A; Jeppesen, L; Mitch, CH; Peters, SC; Rimvall, K; Sauerberg, P; Shannon, HE; Sheardown, MJ; Ward, JS; Whitesitt, CA; Zhang, W | 1 |
| Cohen, ML; Stengel, PW | 1 |
| Dai, J; Li, Z; Meltzer, HY; Roseman, AS; Snigdha, S | 1 |
| Matera, C; Tata, AM | 1 |
2 review(s) available for xanomeline and quinuclidines
| Article | Year |
|---|---|
M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update.
Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; GTP-Binding Proteins; Humans; Ligands; Muscarinic Agonists; Nerve Growth Factors; PC12 Cells; Phosphorylation; Pyridines; Quinuclidines; Rats; Receptors, Cholinergic; Signal Transduction; tau Proteins; Thiadiazoles; Thiophenes | 1996 |
Pharmacological approaches to targeting muscarinic acetylcholine receptors.
Topics: Alzheimer Disease; Animals; Humans; Muscarinic Agonists; Pyridines; Quinuclidines; Receptors, Muscarinic; Sjogren's Syndrome; Thiadiazoles; Thiophenes | 2014 |
1 trial(s) available for xanomeline and quinuclidines
| Article | Year |
|---|---|
M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update.
Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; GTP-Binding Proteins; Humans; Ligands; Muscarinic Agonists; Nerve Growth Factors; PC12 Cells; Phosphorylation; Pyridines; Quinuclidines; Rats; Receptors, Cholinergic; Signal Transduction; tau Proteins; Thiadiazoles; Thiophenes | 1996 |
3 other study(ies) available for xanomeline and quinuclidines
| Article | Year |
|---|---|
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
Topics: Animals; Binding, Competitive; Brain Chemistry; Bridged Bicyclo Compounds, Heterocyclic; Cholinergic Agents; Cholinesterase Inhibitors; Dihydropyridines; Dose-Response Relationship, Drug; Hydrolysis; Hypothermia; Imines; Lithium; Male; Mice; Mice, Inbred Strains; Muscarinic Agonists; Oximes; Parasympathomimetics; Phosphatidylinositols; Physostigmine; Pilocarpine; Pyridines; Quinuclidines; Radioligand Assay; Salivation; Tacrine; Tetrazoles; Thiadiazoles; Tremor | 1998 |
Low-affinity M(2) receptor binding state mediates mouse atrial bradycardia: comparative effects of carbamylcholine and the M(1) receptor agonists sabcomeline and xanomeline.
Topics: Animals; Atropine; Bradycardia; Carbachol; Drug Interactions; Heart; Heart Rate; Imines; In Vitro Techniques; Mice; Muscarinic Agonists; Pyridines; Quinuclidines; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptors, Muscarinic; Thiadiazoles | 2001 |
Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine
Topics: Acetylcholine; Animals; Antipsychotic Agents; Benzoxazines; Brain; Clozapine; Dopamine; Drug Synergism; Imines; Male; Nucleus Accumbens; Pirenzepine; Prefrontal Cortex; Pyridines; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Risperidone; Thiadiazoles | 2008 |